Ultrahuman, a Bengaluru, India-based healthtech wearable glucose tracker, raised $17.5m in Series B funding.
Backers included Alpha Wave Incubation (AWI), managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund, as well as Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra and Roman Saini. The round brought total funds raised so far to $25m.
The company intends to use the funds for geographical expansion and improvement of its biomarker technology.
Mohit Kumar and Vatsal Singhal, Ultrahuman provides an advanced metabolic fitness platform which helps people create long-term habits and changes via instant nudges and deep health insights instead of diets and strict exercise routines. The Ultrahuman Cyborg wearable helps people optimize their exercise and nutrition based on glucose biomarkers. The wearable, launched in June 2021, has already amassed thousands of users in the waitlist.